Presa M, Pérez-Ruiz F, Oyagüez I

2nd line treatment with lesinurad and allopurinol versus febuxostat for management of hyperuricemia: a cost-effectiveness analysis for Spanish patients

European Congress of Rheumatology 2019 (EULAR). Madrid. 12-15 jun 2019